Actively Recruiting

Phase Not Applicable
Age: 19Years +
All Genders
NCT06227754

OCT Versus Angiography for Culprit Lesion Revascularization in Acute Myocardial Infarction PatiEnts

Led by Chonnam National University Hospital · Updated on 2026-05-08

1500

Participants Needed

18

Research Sites

405 weeks

Total Duration

On this page

Sponsors

C

Chonnam National University Hospital

Lead Sponsor

S

Samsung Medical Center

Collaborating Sponsor

AI-Summary

What this Trial Is About

The aim of the study is to compare clinical outcomes between optical coherence tomography-guided versus angiography-guided percutaneous coronary intervention (PCI) in patients with acute myocardial infarction (AMI).

CONDITIONS

Official Title

OCT Versus Angiography for Culprit Lesion Revascularization in Acute Myocardial Infarction PatiEnts

Who Can Participate

Age: 19Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Subject must be at least 19 years of age
  • Acute ST-segment elevation myocardial infarction (STEMI) defined as ST-segment elevation ≥0.1 mV in ≥2 contiguous leads or newly developed left bundle-branch block
  • Primary percutaneous coronary intervention (PCI) within less than 12 hours after symptom onset for STEMI patients
  • Able to understand risks, benefits, and treatment alternatives and provide written informed consent
Not Eligible

You will not qualify if you...

  • Target lesions not suitable for PCI by operator's decision
  • Ostial lesions located in left main vessel or right coronary artery (left main body or distal bifurcation lesions may be enrolled at operator's discretion)
  • Creatinine clearance ≤30 ml/min/1.73 m2 and not on dialysis (dialysis-dependent patients eligible regardless of clearance)
  • Cardiogenic shock (Killip class IV) at presentation
  • Intolerance to Aspirin, Clopidogrel, Prasugrel, Ticagrelor, Heparin, or Everolimus
  • Known true anaphylaxis to contrast medium
  • Pregnancy or breastfeeding
  • Non-cardiac conditions with life expectancy less than 2 years or that risk protocol non-compliance
  • Unwillingness or inability to comply with study procedures

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 18 locations

1

Kyungpook National University Hospital

Daegu, Daegu, South Korea, 41944

Actively Recruiting

2

Yeungnam University Medical Center

Daegu, Daegu, South Korea, 42415

Actively Recruiting

3

Daegu Catholic University Medical Center

Daegu, Daegu, South Korea, 42472

Actively Recruiting

4

Chonnam National University

Gwangju, Gwangju, South Korea, 61469

Actively Recruiting

5

Wonkwang University Hospital

Iksan, Iksan, South Korea, 54538

Actively Recruiting

6

International St. Mary's Hospital

Incheon, Incheon, South Korea, 22711

Actively Recruiting

7

Jeju National University Hospital

Jeju City, Jeju-do, South Korea, 63241

Actively Recruiting

8

Jeonbuk National University Hospital

Jeonju, Jeonju, South Korea, 54907

Actively Recruiting

9

Gyeongsang National University Hospital

Jinju, Jinju, South Korea, 52727

Actively Recruiting

10

Kyung Hee University Hospital

Seoul, Seoul, South Korea, 02447

Actively Recruiting

11

Samsung Medical Center

Seoul, Seoul, South Korea, 06351

Actively Recruiting

12

Chung-Ang University Hospital

Seoul, Seoul, South Korea, 06973

Actively Recruiting

13

Ewha Womans University Seoul Hospital

Seoul, Seoul, South Korea, 07804

Actively Recruiting

14

Ewha Womans University Mokdong Hospital

Seoul, Seoul, South Korea, 07985

Actively Recruiting

15

Korea University Guro Hospital

Seoul, Seoul, South Korea, 08308

Actively Recruiting

16

St. Carollo Hospital

Suncheon, Suncheon, South Korea, 57931

Actively Recruiting

17

Uijeongbu St Mary's Hospital

Uijeongbu-si, Uijeongbu, South Korea, 11765

Actively Recruiting

18

Ulsan University Hospital

Ulsan, Ulsan, South Korea, 44033

Actively Recruiting

Loading map...

Research Team

S

Seung Hun Lee, MD, PhD

CONTACT

Y

Young Joon Hong, MD, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here